Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease

被引:4
|
作者
Zailaie, Samar A. [1 ]
Khoja, Basmah B. [1 ]
Siddiqui, Jumana J. [2 ]
Mawardi, Mohammad H. [3 ]
Heaphy, Emily [1 ]
Aljagthmi, Amjad [1 ]
Sergi, Consolato M. [4 ,5 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr Jeddah KFSHR, Res Ctr, Jeddah 21499, Saudi Arabia
[2] King Abdulaziz Univ, Fac Sci, Biochem Dept, Jeddah 21589, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr Jeddah KFSHR, Med Dept, Gastroenterol Sect, Jeddah 21499, Saudi Arabia
[4] Univ Ottawa, Childrens Hosp Eastern Ontario CHEO, Ottawa, ON K1H 8L1, Canada
[5] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2R3, Canada
关键词
ncRNA; miRNA; PiwiRNA; LncRNA; CircRNA; NAFLD; NASH; oxidative stress; metabolic dysfunction; insulin resistance; HEPATIC STELLATE CELLS; PIWI-INTERACTING RNA; FIBROSIS; STEATOHEPATITIS; METABOLISM; PROGRESSION; ACTIVATION; PATHWAY; GLUCOSE; OBESITY;
D O I
10.3390/ncrna10010010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-coding RNAs (ncRNAs) are RNA molecules that do not code for protein but play key roles in regulating cellular processes. NcRNAs globally affect gene expression in diverse physiological and pathological contexts. Functionally important ncRNAs act in chromatin modifications, in mRNA stabilization and translation, and in regulation of various signaling pathways. Non-alcoholic fatty liver disease (NAFLD) is a set of conditions caused by the accumulation of triacylglycerol in the liver. Studies of ncRNA in NAFLD are limited but have demonstrated that ncRNAs play a critical role in the pathogenesis of NAFLD. In this review, we summarize NAFLD's pathogenesis and clinical features, discuss current treatment options, and review the involvement of ncRNAs as regulatory molecules in NAFLD and its progression to non-alcoholic steatohepatitis (NASH). In addition, we highlight signaling pathways dysregulated in NAFLD and review their crosstalk with ncRNAs. Having a thorough understanding of the disease process's molecular mechanisms will facilitate development of highly effective diagnostic and therapeutic treatments. Such insights can also inform preventive strategies to minimize the disease's future development.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] The Roles of Small Extracellular Vesicles and Small Extracellular Vesicles-derived Non-coding RNA in Non-alcoholic Fatty Liver Disease
    Li, Xiang
    Li, Ye
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2024, 51 (05) : 1054 - 1066
  • [22] The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease
    Francque, Sven M.
    EUROPEAN CARDIOLOGY REVIEW, 2014, 9 (01) : 10 - 15
  • [23] The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease
    Perseghin, Gianluca
    DIGESTIVE DISEASES, 2010, 28 (01) : 210 - 213
  • [24] Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice
    Guo, Jun
    Zhou, Yuan
    Cheng, Yafen
    Fang, Weiwei
    Hu, Gang
    Wei, Jie
    Lin, Yajun
    Man, Yong
    Guo, Lixin
    Sun, Mingxiao
    Cui, Qinghua
    Li, Jian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (04) : 1487 - 1505
  • [25] The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Zhang, Chunye
    Liu, Shuai
    Yang, Ming
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (02) : 148 - 161
  • [26] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [27] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [28] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [29] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290): : 2212 - 2224
  • [30] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15